FSD Pharma Inc. | WebDisclosure

Basculer en Français

9805	Companies
196647	Keywords
127661	Articles
104550	Press releases

Home
Companies
FSD Pharma Inc.

PRESS RELEASE

published on 05/31/2024 at 13:30, 1 year 8 months ago

FSD Pharma, Inc. Wins Petition to Confirm Arbitration Awards Entered Against Dr. Raza Bokhari Totaling Over $3 Million CAD, Plus Interest
FSD Pharma Inc. confirms arbitration awards against former CEO Dr. Raza Bokhari. United States District Court grants final judgment for monetary damages. Company focuses on biopharmaceutical solutions for neurodegenerative disorders

FSD Pharma Inc. Arbitration Awards Neurodegenerative Disorders United States District Court Biopharmaceutical Solutions
BRIEF

published on 05/28/2024 at 14:05, 1 year 8 months ago

FSD Pharma soumet un protocole d'essai clinique pour Unbuzzd™ dans le traitement de l'intoxication alcoolique aiguë

FSD Pharma Essai Clinique Unbuzzd™ Intoxication Alcoolique Essai METAL-2
BRIEF

published on 05/28/2024 at 14:05, 1 year 8 months ago

FSD Pharma Submits Clinical Trial Protocol for Unbuzzd™ in Acute Alcohol Intoxication

FSD Pharma Clinical Trial Unbuzzd™ Alcohol Intoxication METAL-2 Trial
PRESS RELEASE

published on 05/28/2024 at 14:00, 1 year 8 months ago

FSD Pharma Submits a Clinical Trial Protocol to Study the Safety and Efficacy of Unbuzzd(TM) in Acute Alcohol Intoxication
FSD Pharma submits clinical trial protocol for Unbuzzd(TM) to assess safety and efficacy in a crossover design trial to study effects on alcohol intoxication. Dr. Andrzej Chruscinski comments on the milestone reached

FSD Pharma Unbuzzd(TM) Alcohol Intoxication Clinical Trial Protocol Dr. Andrzej Chruscinski
BRIEF

published on 05/24/2024 at 20:39, 1 year 8 months ago

FSD Pharma annonce un accord de relations avec les investisseurs avec IR Agency LLC

Biopharmaceutique FSD Pharma Relations Avec Les Investisseurs Agence RI Psychéeutiques Lucides
BRIEF

published on 05/24/2024 at 20:39, 1 year 8 months ago

FSD Pharma Announces Investor Relations Agreement with IR Agency LLC

Investor Relations FSD Pharma Biopharmaceutical IR Agency Lucid Psycheceuticals
PRESS RELEASE

published on 05/24/2024 at 20:34, 1 year 8 months ago

FSD Pharma Provides Corporate Update
FSD Pharma Inc. enters investor relations services agreement with IR Agency LLC, focusing on communicating information to the financial community. Company building innovative biotech solutions

Investor Relations FSD Pharma Inc. Biopharmaceutical Innovative Assets IR Agency LLC
BRIEF

published on 05/16/2024 at 14:05, 1 year 8 months ago

FSD Pharma Announces New Packaging for Unbuzzd™ Beverage

FSD Pharma Beverage Industry Unbuzzd New Packaging Responsible Drinking
BRIEF

published on 05/16/2024 at 14:05, 1 year 8 months ago

FSD Pharma annonce un nouvel emballage pour la boisson Unbuzzd™

FSD Pharma L'industrie Des Boissons Consommation Responsable Unbuzzd Nouvel Emballage
PRESS RELEASE

published on 05/16/2024 at 14:00, 1 year 8 months ago

FSD Pharma Provides Update on Celly Nu's New Packaging for unbuzzd(TM)
FSD Pharma Inc. announces new packaging and logo for unbuzzd™ beverage product in collaboration with Celly Nutrition Corp. and Six+One, set to launch this summer, targeting alcohol metabolizing and promoting alertness

FSD Pharma Inc. Celly Nutrition Corp. Unbuzzd Six+One Packaging Logo

Accesswire

Published on 02/05/2026 at 01:35, 5 hours ago

Dr. Ruben Shiffman Files Early Warning Report in Respect of Greenland Resources
Published on 02/05/2026 at 00:00, 6 hours 35 minutes ago

Onco-Innovations Announces Filing of Preliminary Base Shelf Prospectus
Published on 02/04/2026 at 22:25, 8 hours 10 minutes ago

55 North Mining Announces Flow-Through Financing
Published on 02/04/2026 at 18:00, 12 hours 35 minutes ago

Lithium South AGSM Update
Published on 02/04/2026 at 16:15, 14 hours 20 minutes ago

Trans Canada Gold Enters into an Option Agreement with Bear Mountain Gold Mines to Acquire a 60% Interest in the Harrison Lake District Scale Gold Property, with $10.0 Million Dollars in Prior Exploration Expenditures

View all ACCESSWIRE

EQS Group

Published on 02/04/2026 at 20:54, 9 hours 41 minutes ago

Elmos Semiconductor SE is planning to distribute 36 million Euro to shareholders for the fiscal year 2025
Published on 02/04/2026 at 20:36, 9 hours 59 minutes ago

EQS-Adhoc: Elmos Semiconductor SE approves share buyback program via the stock exchange of 10 million Euro and dividend proposal of 1.50 Euro per share for fiscal year 2025
Published on 02/04/2026 at 20:00, 10 hours 35 minutes ago

Belgium's Ingmar De Vos elected to Executive Board of International Olympic Committee
Published on 02/04/2026 at 18:55, 11 hours 40 minutes ago

Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/04/2026 at 18:40, 11 hours 55 minutes ago

Robin Zeng: Unlocking the Sustainable Energy Era with Zero-Carbon Technology

Les Echos

Published on 02/04/2026 at 18:04, 12 hours 31 minutes ago

Capital et droits de vote au 31 janvier 2026
Published on 02/04/2026 at 18:04, 12 hours 31 minutes ago

Total number of voting rights and shares making up the share capital at January 31, 2026
Published on 02/04/2026 at 17:45, 12 hours 50 minutes ago

Information concerning the total number of voting rights and shares 2026 01 31
Published on 02/04/2026 at 17:45, 12 hours 50 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 02/04/2026 at 17:45, 12 hours 50 minutes ago

Janvier 2026

View all LES ECHOS COMFI WIRE